Heptares eyes promise of the East as it seeks out new partnerships
This article was originally published in Scrip
Executive Summary
Heptares Therapeutics has already established a solid link with Japan through its G-protein coupled receptor (GPCR) drug discovery collaboration with Takeda signed nearly a year ago, which seems to have piqued the attention of other potential partners in the country.